Global Drug Discovery and Preclinical CRO Supply, Demand and Key Producers, 2023-2029
The global Drug Discovery and Preclinical CRO market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Drug Discovery and Preclinical CRO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Discovery and Preclinical CRO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Discovery and Preclinical CRO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Discovery and Preclinical CRO total market, 2018-2029, (USD Million)
Global Drug Discovery and Preclinical CRO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Drug Discovery and Preclinical CRO total market, key domestic companies and share, (USD Million)
Global Drug Discovery and Preclinical CRO revenue by player and market share 2018-2023, (USD Million)
Global Drug Discovery and Preclinical CRO total market by Type, CAGR, 2018-2029, (USD Million)
Global Drug Discovery and Preclinical CRO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Drug Discovery and Preclinical CRO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv and ChemPartner, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Discovery and Preclinical CRO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Drug Discovery and Preclinical CRO Market, By Region:
1. How big is the global Drug Discovery and Preclinical CRO market?
2. What is the demand of the global Drug Discovery and Preclinical CRO market?
3. What is the year over year growth of the global Drug Discovery and Preclinical CRO market?
4. What is the total value of the global Drug Discovery and Preclinical CRO market?
5. Who are the major players in the global Drug Discovery and Preclinical CRO market?
6. What are the growth factors driving the market demand?
This report studies the global Drug Discovery and Preclinical CRO demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drug Discovery and Preclinical CRO, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drug Discovery and Preclinical CRO that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drug Discovery and Preclinical CRO total market, 2018-2029, (USD Million)
Global Drug Discovery and Preclinical CRO total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Drug Discovery and Preclinical CRO total market, key domestic companies and share, (USD Million)
Global Drug Discovery and Preclinical CRO revenue by player and market share 2018-2023, (USD Million)
Global Drug Discovery and Preclinical CRO total market by Type, CAGR, 2018-2029, (USD Million)
Global Drug Discovery and Preclinical CRO total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Drug Discovery and Preclinical CRO market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON plc, Pharmaron, Inotiv and ChemPartner, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drug Discovery and Preclinical CRO market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Drug Discovery and Preclinical CRO Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Drug Discovery
- Preclinical Research
- Pharmaceutical Company
- Biotech Company
- Others
- Charles River
- Wuxi AppTec
- Labcorp
- Eurofins Scientific
- PPD
- ICON plc
- Pharmaron
- Inotiv
- ChemPartner
- JOINN Laboratories
- Evotec
- Medicilon
- Crown Bioscience
- Champions Oncology
- Frontage Laboratories
- Viva Biotech
- Hitgen Inc.
- Shanghai Innostar
1. How big is the global Drug Discovery and Preclinical CRO market?
2. What is the demand of the global Drug Discovery and Preclinical CRO market?
3. What is the year over year growth of the global Drug Discovery and Preclinical CRO market?
4. What is the total value of the global Drug Discovery and Preclinical CRO market?
5. Who are the major players in the global Drug Discovery and Preclinical CRO market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drug Discovery and Preclinical CRO Introduction
1.2 World Drug Discovery and Preclinical CRO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Drug Discovery and Preclinical CRO Total Market by Region (by Headquarter Location)
1.3.1 World Drug Discovery and Preclinical CRO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.3 China Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.4 Europe Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.5 Japan Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.6 South Korea Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.7 ASEAN Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.8 India Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Discovery and Preclinical CRO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Discovery and Preclinical CRO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.2 World Drug Discovery and Preclinical CRO Consumption Value by Region
2.2.1 World Drug Discovery and Preclinical CRO Consumption Value by Region (2018-2023)
2.2.2 World Drug Discovery and Preclinical CRO Consumption Value Forecast by Region (2024-2029)
2.3 United States Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.4 China Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.5 Europe Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.6 Japan Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.7 South Korea Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.8 ASEAN Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.9 India Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
3 WORLD DRUG DISCOVERY AND PRECLINICAL CRO COMPANIES COMPETITIVE ANALYSIS
3.1 World Drug Discovery and Preclinical CRO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drug Discovery and Preclinical CRO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drug Discovery and Preclinical CRO in 2022
3.2.3 Global Concentration Ratios (CR8) for Drug Discovery and Preclinical CRO in 2022
3.3 Drug Discovery and Preclinical CRO Company Evaluation Quadrant
3.4 Drug Discovery and Preclinical CRO Market: Overall Company Footprint Analysis
3.4.1 Drug Discovery and Preclinical CRO Market: Region Footprint
3.4.2 Drug Discovery and Preclinical CRO Market: Company Product Type Footprint
3.4.3 Drug Discovery and Preclinical CRO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drug Discovery and Preclinical CRO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drug Discovery and Preclinical CRO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Drug Discovery and Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Drug Discovery and Preclinical CRO Consumption Value Comparison
4.2.1 United States VS China: Drug Discovery and Preclinical CRO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Drug Discovery and Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Drug Discovery and Preclinical CRO Companies and Market Share, 2018-2023
4.3.1 United States Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
4.4 China Based Companies Drug Discovery and Preclinical CRO Revenue and Market Share, 2018-2023
4.4.1 China Based Drug Discovery and Preclinical CRO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
4.5 Rest of World Based Drug Discovery and Preclinical CRO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Discovery and Preclinical CRO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Drug Discovery
5.2.2 Preclinical Research
5.3 Market Segment by Type
5.3.1 World Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
5.3.2 World Drug Discovery and Preclinical CRO Market Size by Type (2024-2029)
5.3.3 World Drug Discovery and Preclinical CRO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug Discovery and Preclinical CRO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotech Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
6.3.2 World Drug Discovery and Preclinical CRO Market Size by Application (2024-2029)
6.3.3 World Drug Discovery and Preclinical CRO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Charles River
7.1.1 Charles River Details
7.1.2 Charles River Major Business
7.1.3 Charles River Drug Discovery and Preclinical CRO Product and Services
7.1.4 Charles River Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Charles River Recent Developments/Updates
7.1.6 Charles River Competitive Strengths & Weaknesses
7.2 Wuxi AppTec
7.2.1 Wuxi AppTec Details
7.2.2 Wuxi AppTec Major Business
7.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Product and Services
7.2.4 Wuxi AppTec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Wuxi AppTec Recent Developments/Updates
7.2.6 Wuxi AppTec Competitive Strengths & Weaknesses
7.3 Labcorp
7.3.1 Labcorp Details
7.3.2 Labcorp Major Business
7.3.3 Labcorp Drug Discovery and Preclinical CRO Product and Services
7.3.4 Labcorp Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Labcorp Recent Developments/Updates
7.3.6 Labcorp Competitive Strengths & Weaknesses
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Details
7.4.2 Eurofins Scientific Major Business
7.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Product and Services
7.4.4 Eurofins Scientific Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Eurofins Scientific Recent Developments/Updates
7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.5 PPD
7.5.1 PPD Details
7.5.2 PPD Major Business
7.5.3 PPD Drug Discovery and Preclinical CRO Product and Services
7.5.4 PPD Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 PPD Recent Developments/Updates
7.5.6 PPD Competitive Strengths & Weaknesses
7.6 ICON plc
7.6.1 ICON plc Details
7.6.2 ICON plc Major Business
7.6.3 ICON plc Drug Discovery and Preclinical CRO Product and Services
7.6.4 ICON plc Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 ICON plc Recent Developments/Updates
7.6.6 ICON plc Competitive Strengths & Weaknesses
7.7 Pharmaron
7.7.1 Pharmaron Details
7.7.2 Pharmaron Major Business
7.7.3 Pharmaron Drug Discovery and Preclinical CRO Product and Services
7.7.4 Pharmaron Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pharmaron Recent Developments/Updates
7.7.6 Pharmaron Competitive Strengths & Weaknesses
7.8 Inotiv
7.8.1 Inotiv Details
7.8.2 Inotiv Major Business
7.8.3 Inotiv Drug Discovery and Preclinical CRO Product and Services
7.8.4 Inotiv Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Inotiv Recent Developments/Updates
7.8.6 Inotiv Competitive Strengths & Weaknesses
7.9 ChemPartner
7.9.1 ChemPartner Details
7.9.2 ChemPartner Major Business
7.9.3 ChemPartner Drug Discovery and Preclinical CRO Product and Services
7.9.4 ChemPartner Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ChemPartner Recent Developments/Updates
7.9.6 ChemPartner Competitive Strengths & Weaknesses
7.10 JOINN Laboratories
7.10.1 JOINN Laboratories Details
7.10.2 JOINN Laboratories Major Business
7.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Product and Services
7.10.4 JOINN Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 JOINN Laboratories Recent Developments/Updates
7.10.6 JOINN Laboratories Competitive Strengths & Weaknesses
7.11 Evotec
7.11.1 Evotec Details
7.11.2 Evotec Major Business
7.11.3 Evotec Drug Discovery and Preclinical CRO Product and Services
7.11.4 Evotec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Evotec Recent Developments/Updates
7.11.6 Evotec Competitive Strengths & Weaknesses
7.12 Medicilon
7.12.1 Medicilon Details
7.12.2 Medicilon Major Business
7.12.3 Medicilon Drug Discovery and Preclinical CRO Product and Services
7.12.4 Medicilon Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Medicilon Recent Developments/Updates
7.12.6 Medicilon Competitive Strengths & Weaknesses
7.13 Crown Bioscience
7.13.1 Crown Bioscience Details
7.13.2 Crown Bioscience Major Business
7.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Product and Services
7.13.4 Crown Bioscience Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Crown Bioscience Recent Developments/Updates
7.13.6 Crown Bioscience Competitive Strengths & Weaknesses
7.14 Champions Oncology
7.14.1 Champions Oncology Details
7.14.2 Champions Oncology Major Business
7.14.3 Champions Oncology Drug Discovery and Preclinical CRO Product and Services
7.14.4 Champions Oncology Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Champions Oncology Recent Developments/Updates
7.14.6 Champions Oncology Competitive Strengths & Weaknesses
7.15 Frontage Laboratories
7.15.1 Frontage Laboratories Details
7.15.2 Frontage Laboratories Major Business
7.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Product and Services
7.15.4 Frontage Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Frontage Laboratories Recent Developments/Updates
7.15.6 Frontage Laboratories Competitive Strengths & Weaknesses
7.16 Viva Biotech
7.16.1 Viva Biotech Details
7.16.2 Viva Biotech Major Business
7.16.3 Viva Biotech Drug Discovery and Preclinical CRO Product and Services
7.16.4 Viva Biotech Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Viva Biotech Recent Developments/Updates
7.16.6 Viva Biotech Competitive Strengths & Weaknesses
7.17 Hitgen Inc.
7.17.1 Hitgen Inc. Details
7.17.2 Hitgen Inc. Major Business
7.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Product and Services
7.17.4 Hitgen Inc. Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Hitgen Inc. Recent Developments/Updates
7.17.6 Hitgen Inc. Competitive Strengths & Weaknesses
7.18 Shanghai Innostar
7.18.1 Shanghai Innostar Details
7.18.2 Shanghai Innostar Major Business
7.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Product and Services
7.18.4 Shanghai Innostar Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Shanghai Innostar Recent Developments/Updates
7.18.6 Shanghai Innostar Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drug Discovery and Preclinical CRO Industry Chain
8.2 Drug Discovery and Preclinical CRO Upstream Analysis
8.3 Drug Discovery and Preclinical CRO Midstream Analysis
8.4 Drug Discovery and Preclinical CRO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Drug Discovery and Preclinical CRO Introduction
1.2 World Drug Discovery and Preclinical CRO Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Drug Discovery and Preclinical CRO Total Market by Region (by Headquarter Location)
1.3.1 World Drug Discovery and Preclinical CRO Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.3 China Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.4 Europe Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.5 Japan Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.6 South Korea Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.7 ASEAN Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.3.8 India Drug Discovery and Preclinical CRO Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drug Discovery and Preclinical CRO Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drug Discovery and Preclinical CRO Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.2 World Drug Discovery and Preclinical CRO Consumption Value by Region
2.2.1 World Drug Discovery and Preclinical CRO Consumption Value by Region (2018-2023)
2.2.2 World Drug Discovery and Preclinical CRO Consumption Value Forecast by Region (2024-2029)
2.3 United States Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.4 China Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.5 Europe Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.6 Japan Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.7 South Korea Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.8 ASEAN Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
2.9 India Drug Discovery and Preclinical CRO Consumption Value (2018-2029)
3 WORLD DRUG DISCOVERY AND PRECLINICAL CRO COMPANIES COMPETITIVE ANALYSIS
3.1 World Drug Discovery and Preclinical CRO Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Drug Discovery and Preclinical CRO Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Drug Discovery and Preclinical CRO in 2022
3.2.3 Global Concentration Ratios (CR8) for Drug Discovery and Preclinical CRO in 2022
3.3 Drug Discovery and Preclinical CRO Company Evaluation Quadrant
3.4 Drug Discovery and Preclinical CRO Market: Overall Company Footprint Analysis
3.4.1 Drug Discovery and Preclinical CRO Market: Region Footprint
3.4.2 Drug Discovery and Preclinical CRO Market: Company Product Type Footprint
3.4.3 Drug Discovery and Preclinical CRO Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Drug Discovery and Preclinical CRO Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Drug Discovery and Preclinical CRO Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Drug Discovery and Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Drug Discovery and Preclinical CRO Consumption Value Comparison
4.2.1 United States VS China: Drug Discovery and Preclinical CRO Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Drug Discovery and Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Drug Discovery and Preclinical CRO Companies and Market Share, 2018-2023
4.3.1 United States Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
4.4 China Based Companies Drug Discovery and Preclinical CRO Revenue and Market Share, 2018-2023
4.4.1 China Based Drug Discovery and Preclinical CRO Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
4.5 Rest of World Based Drug Discovery and Preclinical CRO Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Drug Discovery and Preclinical CRO Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Drug Discovery
5.2.2 Preclinical Research
5.3 Market Segment by Type
5.3.1 World Drug Discovery and Preclinical CRO Market Size by Type (2018-2023)
5.3.2 World Drug Discovery and Preclinical CRO Market Size by Type (2024-2029)
5.3.3 World Drug Discovery and Preclinical CRO Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Drug Discovery and Preclinical CRO Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Pharmaceutical Company
6.2.2 Biotech Company
6.2.3 Others
6.3 Market Segment by Application
6.3.1 World Drug Discovery and Preclinical CRO Market Size by Application (2018-2023)
6.3.2 World Drug Discovery and Preclinical CRO Market Size by Application (2024-2029)
6.3.3 World Drug Discovery and Preclinical CRO Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 Charles River
7.1.1 Charles River Details
7.1.2 Charles River Major Business
7.1.3 Charles River Drug Discovery and Preclinical CRO Product and Services
7.1.4 Charles River Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 Charles River Recent Developments/Updates
7.1.6 Charles River Competitive Strengths & Weaknesses
7.2 Wuxi AppTec
7.2.1 Wuxi AppTec Details
7.2.2 Wuxi AppTec Major Business
7.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Product and Services
7.2.4 Wuxi AppTec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Wuxi AppTec Recent Developments/Updates
7.2.6 Wuxi AppTec Competitive Strengths & Weaknesses
7.3 Labcorp
7.3.1 Labcorp Details
7.3.2 Labcorp Major Business
7.3.3 Labcorp Drug Discovery and Preclinical CRO Product and Services
7.3.4 Labcorp Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Labcorp Recent Developments/Updates
7.3.6 Labcorp Competitive Strengths & Weaknesses
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Details
7.4.2 Eurofins Scientific Major Business
7.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Product and Services
7.4.4 Eurofins Scientific Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Eurofins Scientific Recent Developments/Updates
7.4.6 Eurofins Scientific Competitive Strengths & Weaknesses
7.5 PPD
7.5.1 PPD Details
7.5.2 PPD Major Business
7.5.3 PPD Drug Discovery and Preclinical CRO Product and Services
7.5.4 PPD Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 PPD Recent Developments/Updates
7.5.6 PPD Competitive Strengths & Weaknesses
7.6 ICON plc
7.6.1 ICON plc Details
7.6.2 ICON plc Major Business
7.6.3 ICON plc Drug Discovery and Preclinical CRO Product and Services
7.6.4 ICON plc Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 ICON plc Recent Developments/Updates
7.6.6 ICON plc Competitive Strengths & Weaknesses
7.7 Pharmaron
7.7.1 Pharmaron Details
7.7.2 Pharmaron Major Business
7.7.3 Pharmaron Drug Discovery and Preclinical CRO Product and Services
7.7.4 Pharmaron Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Pharmaron Recent Developments/Updates
7.7.6 Pharmaron Competitive Strengths & Weaknesses
7.8 Inotiv
7.8.1 Inotiv Details
7.8.2 Inotiv Major Business
7.8.3 Inotiv Drug Discovery and Preclinical CRO Product and Services
7.8.4 Inotiv Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Inotiv Recent Developments/Updates
7.8.6 Inotiv Competitive Strengths & Weaknesses
7.9 ChemPartner
7.9.1 ChemPartner Details
7.9.2 ChemPartner Major Business
7.9.3 ChemPartner Drug Discovery and Preclinical CRO Product and Services
7.9.4 ChemPartner Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 ChemPartner Recent Developments/Updates
7.9.6 ChemPartner Competitive Strengths & Weaknesses
7.10 JOINN Laboratories
7.10.1 JOINN Laboratories Details
7.10.2 JOINN Laboratories Major Business
7.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Product and Services
7.10.4 JOINN Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 JOINN Laboratories Recent Developments/Updates
7.10.6 JOINN Laboratories Competitive Strengths & Weaknesses
7.11 Evotec
7.11.1 Evotec Details
7.11.2 Evotec Major Business
7.11.3 Evotec Drug Discovery and Preclinical CRO Product and Services
7.11.4 Evotec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Evotec Recent Developments/Updates
7.11.6 Evotec Competitive Strengths & Weaknesses
7.12 Medicilon
7.12.1 Medicilon Details
7.12.2 Medicilon Major Business
7.12.3 Medicilon Drug Discovery and Preclinical CRO Product and Services
7.12.4 Medicilon Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Medicilon Recent Developments/Updates
7.12.6 Medicilon Competitive Strengths & Weaknesses
7.13 Crown Bioscience
7.13.1 Crown Bioscience Details
7.13.2 Crown Bioscience Major Business
7.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Product and Services
7.13.4 Crown Bioscience Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 Crown Bioscience Recent Developments/Updates
7.13.6 Crown Bioscience Competitive Strengths & Weaknesses
7.14 Champions Oncology
7.14.1 Champions Oncology Details
7.14.2 Champions Oncology Major Business
7.14.3 Champions Oncology Drug Discovery and Preclinical CRO Product and Services
7.14.4 Champions Oncology Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Champions Oncology Recent Developments/Updates
7.14.6 Champions Oncology Competitive Strengths & Weaknesses
7.15 Frontage Laboratories
7.15.1 Frontage Laboratories Details
7.15.2 Frontage Laboratories Major Business
7.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Product and Services
7.15.4 Frontage Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Frontage Laboratories Recent Developments/Updates
7.15.6 Frontage Laboratories Competitive Strengths & Weaknesses
7.16 Viva Biotech
7.16.1 Viva Biotech Details
7.16.2 Viva Biotech Major Business
7.16.3 Viva Biotech Drug Discovery and Preclinical CRO Product and Services
7.16.4 Viva Biotech Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Viva Biotech Recent Developments/Updates
7.16.6 Viva Biotech Competitive Strengths & Weaknesses
7.17 Hitgen Inc.
7.17.1 Hitgen Inc. Details
7.17.2 Hitgen Inc. Major Business
7.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Product and Services
7.17.4 Hitgen Inc. Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Hitgen Inc. Recent Developments/Updates
7.17.6 Hitgen Inc. Competitive Strengths & Weaknesses
7.18 Shanghai Innostar
7.18.1 Shanghai Innostar Details
7.18.2 Shanghai Innostar Major Business
7.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Product and Services
7.18.4 Shanghai Innostar Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Shanghai Innostar Recent Developments/Updates
7.18.6 Shanghai Innostar Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Drug Discovery and Preclinical CRO Industry Chain
8.2 Drug Discovery and Preclinical CRO Upstream Analysis
8.3 Drug Discovery and Preclinical CRO Midstream Analysis
8.4 Drug Discovery and Preclinical CRO Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Drug Discovery and Preclinical CRO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Drug Discovery and Preclinical CRO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Drug Discovery and Preclinical CRO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drug Discovery and Preclinical CRO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Drug Discovery and Preclinical CRO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Drug Discovery and Preclinical CRO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Drug Discovery and Preclinical CRO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Drug Discovery and Preclinical CRO Players in 2022
Table 12. World Drug Discovery and Preclinical CRO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Drug Discovery and Preclinical CRO Company Evaluation Quadrant
Table 14. Head Office of Key Drug Discovery and Preclinical CRO Player
Table 15. Drug Discovery and Preclinical CRO Market: Company Product Type Footprint
Table 16. Drug Discovery and Preclinical CRO Market: Company Product Application Footprint
Table 17. Drug Discovery and Preclinical CRO Mergers & Acquisitions Activity
Table 18. United States VS China Drug Discovery and Preclinical CRO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Drug Discovery and Preclinical CRO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 23. China Based Drug Discovery and Preclinical CRO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 29. World Drug Discovery and Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Drug Discovery and Preclinical CRO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Drug Discovery and Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Drug Discovery and Preclinical CRO Market Size by Application (2024-2029) & (USD Million)
Table 35. Charles River Basic Information, Area Served and Competitors
Table 36. Charles River Major Business
Table 37. Charles River Drug Discovery and Preclinical CRO Product and Services
Table 38. Charles River Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Charles River Recent Developments/Updates
Table 40. Charles River Competitive Strengths & Weaknesses
Table 41. Wuxi AppTec Basic Information, Area Served and Competitors
Table 42. Wuxi AppTec Major Business
Table 43. Wuxi AppTec Drug Discovery and Preclinical CRO Product and Services
Table 44. Wuxi AppTec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Wuxi AppTec Recent Developments/Updates
Table 46. Wuxi AppTec Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Area Served and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Drug Discovery and Preclinical CRO Product and Services
Table 50. Labcorp Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Drug Discovery and Preclinical CRO Product and Services
Table 56. Eurofins Scientific Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. PPD Basic Information, Area Served and Competitors
Table 60. PPD Major Business
Table 61. PPD Drug Discovery and Preclinical CRO Product and Services
Table 62. PPD Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. PPD Recent Developments/Updates
Table 64. PPD Competitive Strengths & Weaknesses
Table 65. ICON plc Basic Information, Area Served and Competitors
Table 66. ICON plc Major Business
Table 67. ICON plc Drug Discovery and Preclinical CRO Product and Services
Table 68. ICON plc Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ICON plc Recent Developments/Updates
Table 70. ICON plc Competitive Strengths & Weaknesses
Table 71. Pharmaron Basic Information, Area Served and Competitors
Table 72. Pharmaron Major Business
Table 73. Pharmaron Drug Discovery and Preclinical CRO Product and Services
Table 74. Pharmaron Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pharmaron Recent Developments/Updates
Table 76. Pharmaron Competitive Strengths & Weaknesses
Table 77. Inotiv Basic Information, Area Served and Competitors
Table 78. Inotiv Major Business
Table 79. Inotiv Drug Discovery and Preclinical CRO Product and Services
Table 80. Inotiv Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Inotiv Recent Developments/Updates
Table 82. Inotiv Competitive Strengths & Weaknesses
Table 83. ChemPartner Basic Information, Area Served and Competitors
Table 84. ChemPartner Major Business
Table 85. ChemPartner Drug Discovery and Preclinical CRO Product and Services
Table 86. ChemPartner Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ChemPartner Recent Developments/Updates
Table 88. ChemPartner Competitive Strengths & Weaknesses
Table 89. JOINN Laboratories Basic Information, Area Served and Competitors
Table 90. JOINN Laboratories Major Business
Table 91. JOINN Laboratories Drug Discovery and Preclinical CRO Product and Services
Table 92. JOINN Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. JOINN Laboratories Recent Developments/Updates
Table 94. JOINN Laboratories Competitive Strengths & Weaknesses
Table 95. Evotec Basic Information, Area Served and Competitors
Table 96. Evotec Major Business
Table 97. Evotec Drug Discovery and Preclinical CRO Product and Services
Table 98. Evotec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Evotec Recent Developments/Updates
Table 100. Evotec Competitive Strengths & Weaknesses
Table 101. Medicilon Basic Information, Area Served and Competitors
Table 102. Medicilon Major Business
Table 103. Medicilon Drug Discovery and Preclinical CRO Product and Services
Table 104. Medicilon Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Medicilon Recent Developments/Updates
Table 106. Medicilon Competitive Strengths & Weaknesses
Table 107. Crown Bioscience Basic Information, Area Served and Competitors
Table 108. Crown Bioscience Major Business
Table 109. Crown Bioscience Drug Discovery and Preclinical CRO Product and Services
Table 110. Crown Bioscience Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Crown Bioscience Recent Developments/Updates
Table 112. Crown Bioscience Competitive Strengths & Weaknesses
Table 113. Champions Oncology Basic Information, Area Served and Competitors
Table 114. Champions Oncology Major Business
Table 115. Champions Oncology Drug Discovery and Preclinical CRO Product and Services
Table 116. Champions Oncology Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Champions Oncology Recent Developments/Updates
Table 118. Champions Oncology Competitive Strengths & Weaknesses
Table 119. Frontage Laboratories Basic Information, Area Served and Competitors
Table 120. Frontage Laboratories Major Business
Table 121. Frontage Laboratories Drug Discovery and Preclinical CRO Product and Services
Table 122. Frontage Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Frontage Laboratories Recent Developments/Updates
Table 124. Frontage Laboratories Competitive Strengths & Weaknesses
Table 125. Viva Biotech Basic Information, Area Served and Competitors
Table 126. Viva Biotech Major Business
Table 127. Viva Biotech Drug Discovery and Preclinical CRO Product and Services
Table 128. Viva Biotech Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Viva Biotech Recent Developments/Updates
Table 130. Viva Biotech Competitive Strengths & Weaknesses
Table 131. Hitgen Inc. Basic Information, Area Served and Competitors
Table 132. Hitgen Inc. Major Business
Table 133. Hitgen Inc. Drug Discovery and Preclinical CRO Product and Services
Table 134. Hitgen Inc. Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Hitgen Inc. Recent Developments/Updates
Table 136. Shanghai Innostar Basic Information, Area Served and Competitors
Table 137. Shanghai Innostar Major Business
Table 138. Shanghai Innostar Drug Discovery and Preclinical CRO Product and Services
Table 139. Shanghai Innostar Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Drug Discovery and Preclinical CRO Upstream (Raw Materials)
Table 141. Drug Discovery and Preclinical CRO Typical Customers
Table 1. World Drug Discovery and Preclinical CRO Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Drug Discovery and Preclinical CRO Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Drug Discovery and Preclinical CRO Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Drug Discovery and Preclinical CRO Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Drug Discovery and Preclinical CRO Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Drug Discovery and Preclinical CRO Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Drug Discovery and Preclinical CRO Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Drug Discovery and Preclinical CRO Players in 2022
Table 12. World Drug Discovery and Preclinical CRO Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Drug Discovery and Preclinical CRO Company Evaluation Quadrant
Table 14. Head Office of Key Drug Discovery and Preclinical CRO Player
Table 15. Drug Discovery and Preclinical CRO Market: Company Product Type Footprint
Table 16. Drug Discovery and Preclinical CRO Market: Company Product Application Footprint
Table 17. Drug Discovery and Preclinical CRO Mergers & Acquisitions Activity
Table 18. United States VS China Drug Discovery and Preclinical CRO Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Drug Discovery and Preclinical CRO Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
Table 21. United States Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 23. China Based Drug Discovery and Preclinical CRO Companies, Headquarters (Province, Country)
Table 24. China Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 26. Rest of World Based Drug Discovery and Preclinical CRO Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Drug Discovery and Preclinical CRO Revenue Market Share (2018-2023)
Table 29. World Drug Discovery and Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Drug Discovery and Preclinical CRO Market Size by Type (2018-2023) & (USD Million)
Table 31. World Drug Discovery and Preclinical CRO Market Size by Type (2024-2029) & (USD Million)
Table 32. World Drug Discovery and Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Drug Discovery and Preclinical CRO Market Size by Application (2018-2023) & (USD Million)
Table 34. World Drug Discovery and Preclinical CRO Market Size by Application (2024-2029) & (USD Million)
Table 35. Charles River Basic Information, Area Served and Competitors
Table 36. Charles River Major Business
Table 37. Charles River Drug Discovery and Preclinical CRO Product and Services
Table 38. Charles River Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Charles River Recent Developments/Updates
Table 40. Charles River Competitive Strengths & Weaknesses
Table 41. Wuxi AppTec Basic Information, Area Served and Competitors
Table 42. Wuxi AppTec Major Business
Table 43. Wuxi AppTec Drug Discovery and Preclinical CRO Product and Services
Table 44. Wuxi AppTec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Wuxi AppTec Recent Developments/Updates
Table 46. Wuxi AppTec Competitive Strengths & Weaknesses
Table 47. Labcorp Basic Information, Area Served and Competitors
Table 48. Labcorp Major Business
Table 49. Labcorp Drug Discovery and Preclinical CRO Product and Services
Table 50. Labcorp Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Labcorp Recent Developments/Updates
Table 52. Labcorp Competitive Strengths & Weaknesses
Table 53. Eurofins Scientific Basic Information, Area Served and Competitors
Table 54. Eurofins Scientific Major Business
Table 55. Eurofins Scientific Drug Discovery and Preclinical CRO Product and Services
Table 56. Eurofins Scientific Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Eurofins Scientific Recent Developments/Updates
Table 58. Eurofins Scientific Competitive Strengths & Weaknesses
Table 59. PPD Basic Information, Area Served and Competitors
Table 60. PPD Major Business
Table 61. PPD Drug Discovery and Preclinical CRO Product and Services
Table 62. PPD Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. PPD Recent Developments/Updates
Table 64. PPD Competitive Strengths & Weaknesses
Table 65. ICON plc Basic Information, Area Served and Competitors
Table 66. ICON plc Major Business
Table 67. ICON plc Drug Discovery and Preclinical CRO Product and Services
Table 68. ICON plc Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. ICON plc Recent Developments/Updates
Table 70. ICON plc Competitive Strengths & Weaknesses
Table 71. Pharmaron Basic Information, Area Served and Competitors
Table 72. Pharmaron Major Business
Table 73. Pharmaron Drug Discovery and Preclinical CRO Product and Services
Table 74. Pharmaron Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Pharmaron Recent Developments/Updates
Table 76. Pharmaron Competitive Strengths & Weaknesses
Table 77. Inotiv Basic Information, Area Served and Competitors
Table 78. Inotiv Major Business
Table 79. Inotiv Drug Discovery and Preclinical CRO Product and Services
Table 80. Inotiv Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Inotiv Recent Developments/Updates
Table 82. Inotiv Competitive Strengths & Weaknesses
Table 83. ChemPartner Basic Information, Area Served and Competitors
Table 84. ChemPartner Major Business
Table 85. ChemPartner Drug Discovery and Preclinical CRO Product and Services
Table 86. ChemPartner Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. ChemPartner Recent Developments/Updates
Table 88. ChemPartner Competitive Strengths & Weaknesses
Table 89. JOINN Laboratories Basic Information, Area Served and Competitors
Table 90. JOINN Laboratories Major Business
Table 91. JOINN Laboratories Drug Discovery and Preclinical CRO Product and Services
Table 92. JOINN Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. JOINN Laboratories Recent Developments/Updates
Table 94. JOINN Laboratories Competitive Strengths & Weaknesses
Table 95. Evotec Basic Information, Area Served and Competitors
Table 96. Evotec Major Business
Table 97. Evotec Drug Discovery and Preclinical CRO Product and Services
Table 98. Evotec Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Evotec Recent Developments/Updates
Table 100. Evotec Competitive Strengths & Weaknesses
Table 101. Medicilon Basic Information, Area Served and Competitors
Table 102. Medicilon Major Business
Table 103. Medicilon Drug Discovery and Preclinical CRO Product and Services
Table 104. Medicilon Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Medicilon Recent Developments/Updates
Table 106. Medicilon Competitive Strengths & Weaknesses
Table 107. Crown Bioscience Basic Information, Area Served and Competitors
Table 108. Crown Bioscience Major Business
Table 109. Crown Bioscience Drug Discovery and Preclinical CRO Product and Services
Table 110. Crown Bioscience Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Crown Bioscience Recent Developments/Updates
Table 112. Crown Bioscience Competitive Strengths & Weaknesses
Table 113. Champions Oncology Basic Information, Area Served and Competitors
Table 114. Champions Oncology Major Business
Table 115. Champions Oncology Drug Discovery and Preclinical CRO Product and Services
Table 116. Champions Oncology Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Champions Oncology Recent Developments/Updates
Table 118. Champions Oncology Competitive Strengths & Weaknesses
Table 119. Frontage Laboratories Basic Information, Area Served and Competitors
Table 120. Frontage Laboratories Major Business
Table 121. Frontage Laboratories Drug Discovery and Preclinical CRO Product and Services
Table 122. Frontage Laboratories Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Frontage Laboratories Recent Developments/Updates
Table 124. Frontage Laboratories Competitive Strengths & Weaknesses
Table 125. Viva Biotech Basic Information, Area Served and Competitors
Table 126. Viva Biotech Major Business
Table 127. Viva Biotech Drug Discovery and Preclinical CRO Product and Services
Table 128. Viva Biotech Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Viva Biotech Recent Developments/Updates
Table 130. Viva Biotech Competitive Strengths & Weaknesses
Table 131. Hitgen Inc. Basic Information, Area Served and Competitors
Table 132. Hitgen Inc. Major Business
Table 133. Hitgen Inc. Drug Discovery and Preclinical CRO Product and Services
Table 134. Hitgen Inc. Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Hitgen Inc. Recent Developments/Updates
Table 136. Shanghai Innostar Basic Information, Area Served and Competitors
Table 137. Shanghai Innostar Major Business
Table 138. Shanghai Innostar Drug Discovery and Preclinical CRO Product and Services
Table 139. Shanghai Innostar Drug Discovery and Preclinical CRO Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Drug Discovery and Preclinical CRO Upstream (Raw Materials)
Table 141. Drug Discovery and Preclinical CRO Typical Customers
LIST OF FIGURES
Figure 1. Drug Discovery and Preclinical CRO Picture
Figure 2. World Drug Discovery and Preclinical CRO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Drug Discovery and Preclinical CRO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 13. Drug Discovery and Preclinical CRO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Drug Discovery and Preclinical CRO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Drug Discovery and Preclinical CRO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drug Discovery and Preclinical CRO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drug Discovery and Preclinical CRO Markets in 2022
Figure 27. United States VS China: Drug Discovery and Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Drug Discovery and Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Drug Discovery and Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Drug Discovery and Preclinical CRO Market Size Market Share by Type in 2022
Figure 31. Drug Discovery
Figure 32. Preclinical Research
Figure 33. World Drug Discovery and Preclinical CRO Market Size Market Share by Type (2018-2029)
Figure 34. World Drug Discovery and Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Drug Discovery and Preclinical CRO Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Biotech Company
Figure 38. Others
Figure 39. Drug Discovery and Preclinical CRO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Drug Discovery and Preclinical CRO Picture
Figure 2. World Drug Discovery and Preclinical CRO Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Drug Discovery and Preclinical CRO Total Market Size (2018-2029) & (USD Million)
Figure 4. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Drug Discovery and Preclinical CRO Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Drug Discovery and Preclinical CRO Revenue (2018-2029) & (USD Million)
Figure 13. Drug Discovery and Preclinical CRO Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 16. World Drug Discovery and Preclinical CRO Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 18. China Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 23. India Drug Discovery and Preclinical CRO Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Drug Discovery and Preclinical CRO by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Drug Discovery and Preclinical CRO Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Drug Discovery and Preclinical CRO Markets in 2022
Figure 27. United States VS China: Drug Discovery and Preclinical CRO Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Drug Discovery and Preclinical CRO Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Drug Discovery and Preclinical CRO Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Drug Discovery and Preclinical CRO Market Size Market Share by Type in 2022
Figure 31. Drug Discovery
Figure 32. Preclinical Research
Figure 33. World Drug Discovery and Preclinical CRO Market Size Market Share by Type (2018-2029)
Figure 34. World Drug Discovery and Preclinical CRO Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Drug Discovery and Preclinical CRO Market Size Market Share by Application in 2022
Figure 36. Pharmaceutical Company
Figure 37. Biotech Company
Figure 38. Others
Figure 39. Drug Discovery and Preclinical CRO Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
